首页> 外文期刊>Medicine. >Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study
【24h】

Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study

机译:2004年至2012年韩国大学医院住院患者抗生素使用与耐药模式的趋势及其相关性:一项全国性的多中心研究

获取原文
获取外文期刊封面目录资料

摘要

The aim of this study was to evaluate the changing pattern of antibiotic usage and antimicrobial resistance of bacterial pathogens among hospitalized patients in Korea . We simultaneously investigated the correlation between antimicrobial resistance and antibiotic consumption. Data on total antibiotic prescriptions, patient days, and antimicrobial sensitivity tests among inpatients from 6 university hospitals in Korea in 2004, 2008, and 2012 were collected. The consumption of each antibiotic class was converted to defined daily dose/1000 patient-days by using the anatomical therapeutic chemical classification system by the World Health Organization. We defined third-generation cephalosporins (3rd CEPs), fourth-generation cephalosporins, beta-lactam/beta-lactamase inhibitors, and fluoroquinolones (FQs) as broad-spectrum antibiotics and carbapenems, tigecycline, glycopeptides, oxazolidinone, and polymyxin as antibiotics against multidrug-resistant (MDR) pathogens. A 15.1% decrease in total antibiotic consumption was observed in 2012 compared to that observed in 2004. In contrast, a 10.2% and 70.7% increase in broad-spectrum antibiotics and antibiotics against MDR pathogens were observed, respectively, in the same period. The resistance rate of Escherichia coli to 3rd CEPs (17.6% in 2004, 21.7% in 2008, and 33.8% in 2012, P .001) and ciprofloxacin (37.5% in 2004, 38.7% in 2008, and 46.6% in 2012, P = .001) demonstrated a significantly increasing trend. Similarly, the resistance rate of Klebsiella pneumoniae to 3rd CEPs (34.3% in 2004, 33.7% in 2008, and 44.5% in 2012, P .001) gradually increased. Resistance of Acinetobacter baumanii and Pseudomonas aeruginosa to imipenem significantly increased throughout the study period ( A baumanii : 8.9% in 2004, 40.8% in 2008, and 65.3% in 2012, P .001; P aeruginosa : 25.1% in 2004, 31.5% in 2008, and 29.7% in 2008, P = .050). The consumption of carbapenems and FQs demonstrated significant positive correlation for resistance of E coli or K pneumoniae to 3rd CEPs as well as E coli or K pneumoniae to ciprofloxacin. Increasing resistance of A baumanii to ciprofloxacin was significantly correlated with increasing consumption of FQs; increasing resistance of A baumanii to imipenem was significantly correlated with increasing consumption of carbapenems. In conclusion, overall antimicrobial resistance increased and consumption of broad-spectrum antibiotics and antibiotics against MDR pathogens subsequently increased in Korean hospitals.
机译:本研究的目的是评估韩国住院患者抗生素使用和细菌病原体的耐药性变化情况。我们同时调查了抗菌素耐药性和抗生素消耗之间的相关性。收集了2004年,2008年和2012年韩国6所大学医院住院患者的抗生素处方总数,患者住院天数和抗菌素敏感性测试数据。通过使用世界卫生组织的解剖治疗化学分类系统,将每种抗生素的消耗量转换为规定的每日剂量/ 1000个患者-天。我们将第三代头孢菌素(3rd CEPs),第四代头孢菌素,β-内酰胺/β-内酰胺酶抑制剂和氟喹诺酮(FQs)定义为广谱抗生素和碳青霉烯类药物,替加环素,糖肽,恶唑烷酮和多粘菌素作为针对多药的抗生素耐药(MDR)病原体。与2004年相比,2012年的抗生素总消费量减少了15.1%。相比之下,同期,广谱抗生素和抗MDR病原体的抗生素分别增加了10.2%和70.7%。大肠杆菌对第3种CEP的耐药率(2004年为17.6%,2008年为21.7%,2012年为33.8%,P <.001)和环丙沙星(2004年为37.5%,2008年为38.7%,2012年为46.6%), P = .001)表现出明显的增长趋势。同样,肺炎克雷伯菌对第三种CEP的耐药率(2004年为34.3%,2008年为33.7%,2012年为44.5%,P <.001)逐渐增加。在整个研究期间,鲍曼不动杆菌和铜绿假单胞菌对亚胺培南的耐药性显着增加(鲍曼不动产:2004年为8.9%,2008年为40.8%,2012年为65.3%,P <.001;铜绿假单胞菌:2004年为25.1%,2004年为31.5% (2008年为29.7%,P = .050)。碳青霉烯类和FQ的消耗量显示,大肠杆菌或肺炎克雷伯菌对第三种CEP的耐药性以及大肠杆菌或肺炎克雷伯菌对环丙沙星的耐药性呈正相关。鲍曼不动杆菌对环丙沙星的耐药性增加与FQ的消耗量显着相关。鲍曼不动杆菌对亚胺培南的抗药性增加与碳青霉烯类药物的消费量增加显着相关。总之,在韩国医院中,总体抗菌素耐药性增加,广谱抗生素和抗MDR病原体的抗生素的消费随之增加。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号